Policy researcher Dean W. Ball highlights a five-week surge of major breakthroughs in gene editing, obesity, and oncology

Positive users highlight exciting simultaneous advances in AI radiology, gene editing, and GLP-1 drugs that could sharply cut cancer and heart disease deaths, while negative users fear long-term catastrophic effects from gene editing.

21 comments with sentiment. View comments.